New fill/finish partnership with BioConnection provides end-to-end drug product development under 1 contract! Read the press release

About Us
Our Services
News & Resources
- News & Blogs
- Resources
Careers

Search

Contact Us

Search

Contact Us

About Us
Our Services
News & Resources
- News & Blogs
- Resources
Careers

Our Company

About Us
Our History
Mission & Values
Executive Leadership

Locations

Global Facilities Network
Seattle
Boulder
Copenhagen
Heidelberg
Milan
Chiba
Longmont

Policies

Environment, Health & Safety
Group Privacy Policies

Offerings

Mammalian
Microbial
pDNA
Viral Vectors
Cell Therapy
mRNA

Services

Tech Transfer
Process Development
Cell Line Development
Analytical & Formulation Development
Process Validation
cGMP Manufacturing
Quality Systems & Inspection Management
Fill & Finish Services

Specialized Platforms & Programs

AGCellerate™ mAb & LVV Programs
ProntoLVV™ Lentiviral Vector Platform
BravoAAV™ Adeno-Associated Vector Platform
Proveo™ ADC Program
CMC Jumpstart™ Program

News & Blogs

Press Releases
Biopharma Thought Leadership Blog
Events & Conferences

Resources

Research & Scientific Content
Fact Sheets
Case Studies
Video Library
Media Kit

Fact Sheet Quick Links

Global cGMP Manufacturing (PDF)
CHEF1^TM Expression Technology (PDF)
Mammalian Capabilities (PDF)
Microbial Capabilities (PDF)
Cell Therapy Capabilities (PDF)
Viral Vector Capabilities (PDF)
Plasmid DNA Capabilities (PDF)
Messenger RNA Capabilities (PDF)

Join Us

Career Opportunities

What Drives Us

Life at a CDMO
Diversity, Equity and Inclusion

Meet Our Teams

Seattle
Boulder
Copenhagen
Heidelberg
Milan
Chiba

Press Releases

Find the latest news on AGC Biologics partnerships, product approvals, site expansions, leadership updates, new programs, and more.

mRNA Content

Illustration of new AGC Biologics Yokohama Site

1 min read

AGC Biologics selects Cytiva to provide FlexFactory platforms in new biomanufacturing facility in Japan

April 25, 2024 at 5:53 AM

Mammalian & mAbs Press Release Business Updates mRNA Content

Read press release

AGC Biologics new manufacturing facility - Yokohama, Japan

1 min read

AGC Biologics announces plans for New Manufacturing Site in Yokohama Japan

January 4, 2024 at 6:01 AM

Cell & Gene Therapy Mammalian & mAbs Press Release Business Updates mRNA Content

Read press release

Heildelberg ribbon cutting for grand opening of new expansion for pDNA and mRNA.

1 min read

AGC Biologics Completes pDNA and mRNA Expansion at Heidelberg location

October 12, 2023 at 6:34 AM

Press Release Business Updates mRNA Content Plasmid DNA Content

Read press release

Our Mission

To work side by side with our customers in order to improve patients’ lives by bringing new biopharmaceuticals to market.

Links

About Us
Our Services
Locations
Careers
Contact Us
Media Kit

News

Featured Blog Image

AGC Biologics’ Milan Site to Prepare Lentiviral Vector Commercial Manufacturing for Adaptimmune’s Lete-Cel Product

Today, we announced a development and manufacturing services agreement with Adaptimmune, a company...

Events

Featured Blog Image

NextGen Biomed, March 12-14

Date: March 12-14, 2025

Location: London, UK

Event Website: ...

Legal & Compliance

© 2025 AGC Biologics. All Rights Reserved.

AGC Inc. Group